Bio-Techne (TECH) Free Cash Flow (2009 - 2026)
Bio-Techne's quarterly Free Cash Flow came in at $77.6 million in Q1 2026, up 150.27% year-on-year from $31.0 million in Q1 2025, and up 1.42% quarter-over-quarter from $76.5 million in Q4 2025.
Bio-Techne has reported Free Cash Flow for 18 years, with the latest figure at $77.6 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 150.27% year-over-year to $77.6 million; the trailing twelve-month figure through Mar 2026 stood at $269.6 million (up 22.13% YoY), and the FY2025 full-year result was $256.6 million, up 8.66% from the prior year.
- Free Cash Flow for Q1 2026 stood at $77.6 million, up from $76.5 million in the prior quarter.
- The five-year high for Free Cash Flow was $93.3 million in Q2 2025, with the low at $22.2 million in Q3 2025.
- Average Free Cash Flow over 5 years is $60.7 million, with a median of $58.3 million recorded in 2022.
- Year-over-year, Free Cash Flow slumped 59.39% in 2025 and soared 150.27% in 2026.
- Tracing TECH's Free Cash Flow over 5 years: stood at $58.3 million in 2022, then grew by 17.12% to $68.3 million in 2023, then gained by 13.59% to $77.5 million in 2024, then fell by 1.34% to $76.5 million in 2025, then rose by 1.42% to $77.6 million in 2026.
- The last three Free Cash Flow figures came in at $77.6 million (Q1 2026), $76.5 million (Q4 2025), and $22.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 77.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.58 Mn |
| Mar 31, 2026 | 77.58 Mn |
| Dec 31, 2025 | 76.49 Mn |
| Dec 31, 2025 | 76.49 Mn |
| Sep 30, 2025 | 22.22 Mn |
| Sep 30, 2025 | 22.22 Mn |
| Jun 30, 2025 | 93.31 Mn |
| Jun 30, 2025 | 93.31 Mn |
| Mar 31, 2025 | 31.00 Mn |
| Mar 31, 2025 | 31.00 Mn |
| Dec 31, 2024 | 77.53 Mn |
| Dec 31, 2024 | 77.53 Mn |
| Sep 30, 2024 | 54.72 Mn |
| Sep 30, 2024 | 54.72 Mn |
| Jun 30, 2024 | 57.52 Mn |
| Jun 30, 2024 | 57.52 Mn |
| Mar 31, 2024 | 64.55 Mn |
| Mar 31, 2024 | 64.55 Mn |
| Dec 31, 2023 | 68.25 Mn |
| Dec 31, 2023 | 68.25 Mn |
| Sep 30, 2023 | 45.79 Mn |
| Sep 30, 2023 | 45.79 Mn |
| Jun 30, 2023 | 72.56 Mn |
| Jun 30, 2023 | 72.56 Mn |
| Mar 31, 2023 | 38.79 Mn |
| Mar 31, 2023 | 38.79 Mn |
| Dec 31, 2022 | 58.28 Mn |
| Dec 31, 2022 | 58.28 Mn |
| Sep 30, 2022 | 46.53 Mn |
| Sep 30, 2022 | 46.53 Mn |
| Jun 30, 2022 | 89.15 Mn |
| Jun 30, 2022 | 89.15 Mn |
| Mar 31, 2022 | 58.03 Mn |
| Mar 31, 2022 | 58.03 Mn |
| Dec 31, 2021 | 90.83 Mn |
| Dec 31, 2021 | 90.83 Mn |
| Sep 30, 2021 | 42.36 Mn |
| Sep 30, 2021 | 42.36 Mn |
| Jun 30, 2021 | 110.70 Mn |
| Jun 30, 2021 | 110.70 Mn |
| Mar 31, 2021 | 64.26 Mn |
| Mar 31, 2021 | 64.26 Mn |
| Dec 31, 2020 | 77.82 Mn |
| Dec 31, 2020 | 77.82 Mn |
| Sep 30, 2020 | 55.07 Mn |
| Sep 30, 2020 | 55.07 Mn |
| Jun 30, 2020 | 27.42 Mn |
| Jun 30, 2020 | 27.42 Mn |
| Mar 31, 2020 | 40.19 Mn |
| Mar 31, 2020 | 40.19 Mn |
| Dec 31, 2019 | 55.85 Mn |
| Dec 31, 2019 | 55.85 Mn |
| Sep 30, 2019 | 30.01 Mn |
| Sep 30, 2019 | 30.01 Mn |
| Jun 30, 2019 | 44.25 Mn |
| Jun 30, 2019 | 44.25 Mn |
| Mar 31, 2019 | 34.74 Mn |
| Mar 31, 2019 | 34.74 Mn |
| Dec 31, 2018 | 41.96 Mn |
| Dec 31, 2018 | 41.96 Mn |
| Sep 30, 2018 | 35.26 Mn |
| Sep 30, 2018 | 35.26 Mn |
| Jun 30, 2018 | 59.02 Mn |
| Jun 30, 2018 | 59.02 Mn |
| Mar 31, 2018 | 18.14 Mn |
| Mar 31, 2018 | 18.14 Mn |
| Dec 31, 2017 | 32.85 Mn |
| Dec 31, 2017 | 32.85 Mn |
| Sep 30, 2017 | 39.42 Mn |
| Sep 30, 2017 | 39.42 Mn |
| Jun 30, 2017 | 44.98 Mn |
| Jun 30, 2017 | 44.98 Mn |
| Mar 31, 2017 | 21.00 Mn |
| Mar 31, 2017 | 21.00 Mn |
| Dec 31, 2016 | 38.78 Mn |
| Dec 31, 2016 | 38.78 Mn |
| Sep 30, 2016 | 24.06 Mn |
| Sep 30, 2016 | 24.06 Mn |
| Jun 30, 2016 | 33.59 Mn |
| Jun 30, 2016 | 33.59 Mn |
| Mar 31, 2016 | 34.30 Mn |
| Mar 31, 2016 | 34.30 Mn |
| Dec 31, 2015 | 33.65 Mn |
| Dec 31, 2015 | 33.65 Mn |
| Sep 30, 2015 | 25.71 Mn |
| Sep 30, 2015 | 25.71 Mn |
| Jun 30, 2015 | 30.21 Mn |
| Jun 30, 2015 | 30.21 Mn |
| Mar 31, 2015 | 25.85 Mn |
| Mar 31, 2015 | 25.85 Mn |
| Dec 31, 2014 | 32.58 Mn |
| Dec 31, 2014 | 32.58 Mn |
| Sep 30, 2014 | 30.81 Mn |
| Sep 30, 2014 | 30.81 Mn |
| Jun 30, 2014 | 35.82 Mn |
| Jun 30, 2014 | 35.82 Mn |
| Mar 31, 2014 | 30.67 Mn |
| Mar 31, 2014 | 30.67 Mn |
| Dec 31, 2013 | 27.68 Mn |
| Dec 31, 2013 | 27.68 Mn |
| Sep 30, 2013 | 28.77 Mn |
| Sep 30, 2013 | 28.77 Mn |
| Jun 30, 2013 | 24.64 Mn |
| Jun 30, 2013 | 24.64 Mn |
| Mar 31, 2013 | 26.65 Mn |
| Mar 31, 2013 | 26.65 Mn |
| Dec 31, 2012 | 23.07 Mn |
| Dec 31, 2012 | 23.07 Mn |
| Sep 30, 2012 | 26.75 Mn |
| Sep 30, 2012 | 26.75 Mn |
| Jun 30, 2012 | 36.28 Mn |
| Jun 30, 2012 | 36.28 Mn |
| Mar 31, 2012 | 32.88 Mn |
| Mar 31, 2012 | 32.88 Mn |
| Dec 31, 2011 | 18.24 Mn |
| Dec 31, 2011 | 18.24 Mn |
| Sep 30, 2011 | 33.34 Mn |
| Sep 30, 2011 | 33.34 Mn |
| Jun 30, 2011 | 33.40 Mn |
| Jun 30, 2011 | 33.40 Mn |
| Mar 31, 2011 | 31.79 Mn |
| Mar 31, 2011 | 31.79 Mn |
| Dec 31, 2010 | 28.72 Mn |
| Dec 31, 2010 | 28.72 Mn |
| Sep 30, 2010 | 29.65 Mn |
| Sep 30, 2010 | 29.65 Mn |
| Jun 30, 2010 | 30.66 Mn |
| Jun 30, 2010 | 30.66 Mn |
| Mar 31, 2010 | 21.85 Mn |
| Mar 31, 2010 | 21.85 Mn |
| Dec 31, 2009 | 26.64 Mn |
| Dec 31, 2009 | 26.64 Mn |
| Sep 30, 2009 | 27.47 Mn |
| Sep 30, 2009 | 27.47 Mn |